RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tyme Technologies Stock

Tyme Technologies Stocks 2024

Tyme Technologies Stocks

172.21 M

Ticker

TYME

ISIN

US90238J1034

WKN

A14XMS

In 2024, Tyme Technologies had 172.21 M outstanding stocks, a 0% change from the 172.21 M stocks in the previous year.

The Tyme Technologies Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2025e172.21
2024e172.21
2023e172.21
2022172.21
2021134.25
2020114.53
2019102.35
201890.57
201784.45
201577.85
201452
201352
201247.6
201139

Tyme Technologies shares outstanding

The number of shares was Tyme Technologies in 2023 — This indicates how many shares 172.207 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Tyme Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Tyme Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Tyme Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Tyme Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Tyme Technologies Aktienanalyse

What does Tyme Technologies do?

Tyme Technologies Inc is a biopharmaceutical company specializing in the development of cancer drugs. The company was founded in 2011 by Steve Hoffman in New York City. Tyme Technologies Inc aims to provide a solution for the urgent need for new cancer drugs. The business model of Tyme Technologies Inc focuses on research and development of therapies for various types of cancer. The company takes an innovative approach by targeting the metabolism of tumor cells to combat them. The goal is to provide personalized medicine to cancer patients, tailored to their specific cancer types and with fewer side effects. Tyme Technologies has achieved success in various areas and is actively working on establishing cancer treatment products. The company engages in its own research as well as collaborations with other companies and institutions. One of Tyme Technologies' areas of focus is the research and development of drugs for triple-negative breast cancer. This type of cancer is known to be very aggressive and spreads quickly. Tyme Technologies has developed a promising drug called SM-88, which aims to disrupt the metabolic processes in cancer cells, causing them to die. Another significant project of Tyme Technologies is the research and development of drugs for glioma, a particularly aggressive brain tumor for which there are currently no effective therapies. The company has successfully tested the drug SM-88 in a phase II study for this purpose. Tyme Technologies has also focused on cancer treatment in children. The company has conducted clinical trials for the treatment of neuroblastoma and osteosarcoma, both of which are rare and particularly aggressive types of cancer that mainly affect children. In terms of product offerings, Tyme Technologies has introduced various products to the market. One of them is the NLC-001 immunotherapy program, which focuses on activating the body's immune response against cancer cells. The company has also developed a test procedure for personalizing therapy in patients with triple-negative breast cancer, based on the patient's genetic profile. In summary, Tyme Technologies Inc is an emerging biopharmaceutical company specializing in the development of personalized therapies to combat various types of cancer. With its innovative technology, the company has already achieved significant success, particularly in the development of drugs for triple-negative breast cancer and brain tumors. The company continuously collaborates with other companies and institutions and invests in research and development of new cancer drugs in the long term. Tyme Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Tyme Technologies's Shares Outstanding

Tyme Technologies's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Tyme Technologies’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Tyme Technologies’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Tyme Technologies’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Tyme Technologies stock

How many stocks are there of Tyme Technologies?

The current number of stocks of Tyme Technologies is 172.21 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Tyme Technologies are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Tyme Technologies evolved in recent years?

The number of shares of Tyme Technologies has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Tyme Technologies as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Tyme Technologies?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Tyme Technologies pay?

Over the past 12 months, Tyme Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tyme Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Tyme Technologies?

The current dividend yield of Tyme Technologies is .

When does Tyme Technologies pay dividends?

Tyme Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tyme Technologies?

Tyme Technologies paid dividends every year for the past 0 years.

What is the dividend of Tyme Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tyme Technologies located?

Tyme Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tyme Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tyme Technologies from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Tyme Technologies pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Tyme Technologies in the year 2023?

In the year 2023, Tyme Technologies distributed 0 USD as dividends.

In which currency does Tyme Technologies pay out the dividend?

The dividends of Tyme Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tyme Technologies

Our stock analysis for Tyme Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tyme Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.